Auquan’s Daily Wrap | 6th March: What you might have missed
Three key themes Auquan customers are tracking today.
Brazil GMO Wheat Development
Summary: Brazil has approved using genetically modified (GM) wheat to address concerns over the global wheat supply. The move comes after extensive testing and scrutiny by the country's biosecurity agency, CTNbio.
- Bioceres HB4 wheat has gained approval in Brazil, making it the first GM wheat variety to be approved in the country.
- Brazil has become the second country after Argentina to approve GM wheat, which could lead to wider acceptance of GM wheat in other countries.
- The approval of GM wheat could have significant consequences for the agricultural commodities market, affecting companies such as Cargill, Bunge, and Archer Daniels Midland.
- Future dates to watch include the planting season for wheat in Brazil, which begins in May. The success of GM wheat crops could influence other countries' decisions to approve the use of GM wheat.
- Mar 3 | Brazil approves GMO wheat as food supply fears help convince sceptics
- Mar 3 | Bioceres HB4 wheat gains approval in Brazil
The potential impact of EU Pharma Legislation Reforms on healthcare innovation
Summary: Draft EU pharma legislation changes have raised concerns over innovation and access to medicines. The pharmaceutical industry is calling for more balance, warning of reduced investment in R&D and a shift of innovation outside Europe. Companies including Novartis, Sanofi, GlaxoSmithKline, and Novo Nordisk have expressed concerns.
- The implementation date for the proposed changes is not yet confirmed.
- Italy, France, Germany, Spain, and Belgium are among the countries that will be affected.
- The pharma industry fears the changes will make it harder to produce novel medicines and treatments with stricter regulations.
- The changes also aim to improve patient access to affordable medicines and treatments, with measures such as promoting transparency and monitoring prices.
- 2 Mar | Europe will lose out on medical innovation if draft EU reforms pass
- 24 Feb | Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict
- 16 Jan | Everything you wanted to know about the EU’s pharma reform (but were too afraid to ask)
Dublin Airport Drone Incursions
Summary: Dublin Airport faced six drone incidents in the past few days, causing flight disruptions and forcing flight diversions. The Irish government is split on the issue, and pilots have lost confidence in the government's ability to handle drone threats. Affected companies include Ryanair and Jabyr.
- Multiple drone sightings near Dublin airport caused flight disruptions and diversions and raised concerns about passenger safety.
- The Irish government is split on the issue, and pilots have lost confidence in the government's ability to handle drone threats.
- Affected companies include Ryanair and Jabyr.
- Future dates to watch: any updates on the government's plan to handle drone threats and technological developments to detect and handle drone incidents.
- Mar 3 | Ireland vows to tackle drones after Dublin Airport shut six times
- Mar 3 | Pilots 'losing confidence' in Government to tackle Dublin Airport drones
- Mar 2 | Dublin Airport: Flights diverted over more drone sightings
While you’re here…
Thanks for reading! Portfolio managers use Auquan’s Portfolio Intelligence Engine to understand, track, and minimize risks — and identify hidden opportunities.
Expand the scale and scope of your research and focus only on high-value analysis so you’re always prepared to act ahead of the market.
Visit www.auquan.com to schedule a demo.